Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.44611 | 17 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.41717 | 17 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.42062 | 17 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.35735 | 17 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.36065 | 17 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.48304 | 17 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.43572 | 17 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.39726 | 17 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.37421 | 16 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.40071 | 17 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.40134 | 17 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.38228 | 17 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.41234 | 17 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.40814 | 17 |